Trademark: 97006194
Word
THE MD ANDERSON EXPERIENCE
Status
Dead
Status Code
606
Status Date
Monday, April 3, 2023
Serial Number
97006194
Mark Type
4000
Filing Date
Wednesday, September 1, 2021
Published for Opposition
Tuesday, July 5, 2022
Abandoned Date
Monday, April 3, 2023

Trademark Owner History

Classifications
41 Educational services, namely, development and dissemination of educational materials in printed and electronic format to others in the nature of articles, newsletters, informational flyers, brochures and resource guides in the fields of health, healthcare, cancer and cancer prevention; Providing blogs, on-line resource guides and on-line non-downloadable videos in the fields of health, healthcare, cancer and cancer prevention; Educational services, namely, conducting programs in the fields of health, healthcare, cancer and cancer prevention for patients, caretakers, healthcare professionals, and the public
9 Prerecorded downloadable electronic and digital media featuring articles, newsletters, informational flyers, brochures and on-line resource guides in the fields of health, healthcare, cancer and cancer prevention; Downloadable electronic publications in the nature of blogs, articles, newsletters, informational flyers, brochures and on-line resource guides in the fields of health, healthcare, cancer and cancer prevention; Prerecorded downloadable electronic and digital media featuring educational and course materials in the fields of health, healthcare, cancer and cancer prevention; Downloadable electronic publications in the nature of blogs, articles, newsletters, informational flyers, brochures, and online resource guides featuring educational and course materials in the fields of health, healthcare, cancer and cancer prevention; Downloadable computer software for medical data analysis
36 Charitable fundraising services
35 Promoting public awareness of cancer-related treatment, research and prevention; Business consulting services, namely, business consulting on the establishment, management, and operation of cancer treatment centers for others; medical health care utilization and review services and consulting related thereto
44 Medical services relating to cancer; medical consulting services, namely, consulting on the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, and patient care management; computer information services, namely, providing medical information on cancer and other diseases, oncology and disease management via the internet; providing information, advice and data on cancer prevention, diagnosis, treatments, and recovery; providing health care data analytics and bioinformatics services; health care and medical data analysis services
42 Medical research services; software as a service (SAAS) services featuring software for medical data analysis; data collection service using software to evaluate, analyze, and collect medical data
The name shown in the mark does not identify a living individual.

Trademark Events
Apr 3, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 3, 2023
Abandonment - No Use Statement Filed
Aug 30, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 5, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 5, 2022
Published For Opposition
Jun 15, 2022
Notification Of Notice Of Publication E-Mailed
May 31, 2022
Approved For Pub - Principal Register
May 31, 2022
Examiner's Amendment Entered
May 31, 2022
Notification Of Examiners Amendment E-Mailed
May 31, 2022
Examiners Amendment E-Mailed
May 31, 2022
Examiners Amendment -Written
May 28, 2022
Teas/Email Correspondence Entered
May 27, 2022
Correspondence Received In Law Office
May 27, 2022
Teas Response To Office Action Received
Nov 29, 2021
Notification Of Non-Final Action E-Mailed
Nov 29, 2021
Non-Final Action E-Mailed
Nov 29, 2021
Non-Final Action Written
Nov 29, 2021
Assigned To Examiner
Oct 14, 2021
New Application Office Supplied Data Entered
Sep 4, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24